BiotechTube
Home/Peptinovo Biopharma/Dr. Ren Homan, PhD
DR

Dr. Ren Homan, PhD

Founder, CSO

Peptinovo Biopharma

Therapeutic Areas

Oncology

Peptinovo Biopharma Pipeline

DrugIndicationPhase
PNB-281Solid TumorsPreclinical
PALM™ Tubulin DisruptorsSolid TumorsPreclinical
PALM™ Platinum DrugsSolid TumorsPreclinical
PALM™ GemcitabineSolid TumorsPreclinical

Leadership Team at Peptinovo Biopharma

DB
Dr. Bill Elliott, PhD
Co-Founder, CTO
ST
Steve Tokarz, MBA
CEO
DJ
Dr. Jan Van Tornout, MD
Chief Medical Officer
DW
Dr. Wayne Klohs, PhD
Head of Clinical Design & Oncology Strategy
View full Peptinovo Biopharma profile